Purification method for embryo—derived infectious bronchitis virus (IBV)

Patent metadata

Field	Value
Publication number	US-9701946-B2
Application number	US-201514944223-A
Country	US
Kind code	B2
Filing date	Nov 18, 2015
Priority date	Jan 30, 2015
Publication date	Jul 11, 2017
Grant date	Jul 11, 2017

Abstract

The invention discloses an avian infectious bronchitis virus purification method. The method uses ordinary avian embryo which was affected by avian bronchitis virus. Using the combination of centrifugation, ultrafiltration, concentration, molecular sieve chromatography and ultrafiltration method can effectively remove miscellaneous protein in embryo-derived infectious bronchitis virus antigen, high virus recovery, and have no effect on the activity of avian infectious bronchitis virus. The avian infectious bronchitis virus purified by this method can be directly used in the preparation of avian infectious bronchitis virus vaccine.

First claim

We claim:

1. A purification method for Embryo-derived avian Infectious Bronchitis Virus (IBV), comprising the following steps:
1) Inoculating fertilized eggs containing chicken embryos with avian Infectious Bronchitis Virus;
2) incubating the eggs containing the embryos at 37° C. for 48-96 hours, removing the eggs containing the avian embryos that have died within the first 24 hours during embryo incubation; refrigerating the remaining eggs containing the embryos at 2° C. to 8° C. for 8-16 hours for storage, then collecting the allantoic fluid from the eggs;
3) Centrifuging the allantoic fluid at 4000-6000 rpm for 10-50 min;
4) Ultrafiltrating the centrifugal liquid from step 3) with ultrafiltration membrane which pore size is 30-500 kDa, concentrating the filtrate to 20%-50% of the original volume;
5) Chromatographing the concentrated filtrate with a molecular sieve (with a column height of 30-120 cm packing); loading the concentrated filtrate with a loading volume (5% to 20% of the column volume, eluting the chromatography with PBS buffer solution, and collecting the first protein elution peak as avian infectious bronchitis virus;
6) Ultrafiltrating the avian infectious bronchitis virus elusion from step 5) with ultrafiltration membrane which pore size is 30-500 kDa and concentrating the filtrate to 20%-50% of the original volume.

2. A purification method according to claim 1 , wherein step 1), the fertilized chicken embryo is at 9-11 days of embryonation.

3. A purification method according to claim 1 , wherein step 3), further comprising the centrifugal speed is 4500-5500 rpm.

4. A purification method according to claim 1 , wherein step 3), further comprising the centrifugal time is 20-40 minutes.

5. A purification method according to claim 1 , wherein step 5), further comprising the packing filler of molecular sieve is Superdex™ 200.

6. A purification method according to claim 1 , wherein step 5), further comprising the sample loading volume is 10%-20% of column volume.

7. A purification method according to claim 1 , wherein step 5), further comprising the elution velocity is 2-3 mL/min.

8. A purification method according to claim 1 , the method of purification of avian infectious bronchitis virus applies in the preparation of avian infectious bronchitis virus vaccine.

Assignees

• Zhaoqing Dahuanong Biological Medicine Co Ltd
• Univ South China Agricult

Inventors

• Chen Ruiai
• Xu Jiahua
• Wang Xinqiu
• Zhang Dongxia
• Sun Beibei
• Xie Xiaoyu
• Ren Changbao

Classifications

• C12N2770/20051

  Methods of production or purification of viral material · CPC title

• C12N7/02

  Recovery or purification · CPC title

• C12N7/00 Primary

  Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

• A61P31/14

  for RNA viruses · CPC title